Building the microbiome in health and disease: niche construction and social conflict in bacteria by McNally, Luke & Brown, Sam P.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Building the microbiome in health and disease: niche
construction and social conflict in bacteria
Citation for published version:
McNally, L & Brown, SP 2015, 'Building the microbiome in health and disease: niche construction and social
conflict in bacteria' Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 370, no.
1675, 20140298. DOI: 10.1098/rstb.2014.0298
Digital Object Identifier (DOI):
10.1098/rstb.2014.0298
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Philosophical Transactions of the Royal Society B: Biological Sciences
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
 on July 8, 2015http://rstb.royalsocietypublishing.org/Downloaded from rstb.royalsocietypublishing.orgReview
Cite this article: McNally L, Brown SP. 2015
Building the microbiome in health and disease:
niche construction and social conflict in
bacteria. Phil. Trans. R. Soc. B 370: 20140298.
http://dx.doi.org/10.1098/rstb.2014.0298
Accepted: 9 May 2015
One contribution of 17 to a theme issue
‘Within-host dynamics of infection: from
ecological insights to evolutionary predictions’.
Subject Areas:
behaviour, ecology, evolution, health
and disease and epidemiology, microbiology,
molecular biology
Keywords:
social evolution, niche construction,
cooperation, microbiota, community ecology
Authors for correspondence:
Luke McNally
e-mail: luke.mcnally@ed.ac.uk
Sam P. Brown
e-mail: sam.brown@ed.ac.uk& 2015 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.Building the microbiome in health and
disease: niche construction and social
conflict in bacteria
Luke McNally1,2 and Sam P. Brown1,2
1Centre for Immunity, Infection and Evolution, and 2Institute of Evolutionary Biology, School of Biological
Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK
Microbes collectively shape their environment in remarkable ways via the
products of their metabolism. The diverse environmental impacts of macro-
organisms have been collated and reviewed under the banner of ‘niche
construction’. Here, we identify and review a series of broad and overlapping
classes of bacterial niche construction, ranging from biofilm production to
detoxification or release of toxins, enzymes, metabolites and viruses, and
review their role in shaping microbiome composition, human health and
disease. Some bacterial niche-constructing traits can be seen as extended phe-
notypes, where individuals actively tailor their environment to their benefit
(and potentially to the benefit of others, generating social dilemmas). Other
modifications can be viewed as non-adaptive by-products from a producer
perspective, yet they may lead to remarkable within-host environmental
changes. We illustrate how social evolution and niche construction perspec-
tives offer complementary insights into the dynamics and consequences of
these traits across distinct timescales. This review highlights that by under-
standing the coupled bacterial and biochemical dynamics in human health
and disease we can better manage host health.1. Microbial niche construction
Microbes engage in a remarkable array of behaviours that shape and change
their shared environments (table 1). In short, microbes are prodigious ‘niche
constructors’ [16–20], with construction varying from elaborate and adaptive
extracellular mechanisms that yield collective improvements to a set of focal
‘engineers’ (e.g. secreting molecules to enhance nutrient supply and shelter)
[21–23], to the inevitable environmental degradation [24–30] (from focal
agent’s perspective) that follows from the uptake and consumption of limiting
resources [18,19,31]. Examples in important pathogens include: the production
of the toxin pyocyanin by the opportunistic pathogen Pseudomonas aeruginosa,
which both kills competitors and is toxic to humans [32,33]; biofilm formation
in the nosocomial pathogen Klebsiella pneumonia, which greatly enhances its anti-
biotic resistance [34] and transmission of Shiga toxin encoding phage viruses to
commensal microbes by shigatoxinagenic Escherichia coli, which can both clear
commensal E. coli and amplify production of the often deadly Shiga toxin
[35,36]. Understanding both the consequences of these behaviours on the host
environment and how these consequences shape the ecology and evolution of
pathogens is critical in developing robust treatment strategies for these infections.
Together, the diverse influences of organisms on their environment have
been termed ‘niche construction’, an extremely broad term that can be applied
to any organismal trait that has some (direct or indirect) consequence for the
organism’s environment [37,38]. The breadth of this concept has led some
authors to question its utility [39–41]. Here, we use a combination of concepts
from niche construction and social evolution theory to outline a broad classifi-
cation of how microbes change their environments, to better understand the
Table 1. Examples of microbial niche construction.
trait niche construction effect references
respiration reduced partial pressure of O2-favouring anaerobes
bioﬁlm production modiﬁes spatial structure and chemical environment [1,2]
extracellular enzymes and scavenging molecules
(e.g. invertase, proteases, siderophores)
modiﬁes the nutrient environment [3,4]
resistance to phages ‘herd immunity’ can reduce the effects of phages on others [5]
antibiotic production modiﬁes composition of the microbiota [6,7]
antibiotic detoxiﬁcation (e.g. b-lactamase) removes toxic chemicals from environment, alters microbiota [8]
excretion of metabolic by-products inhibits or promotes growth of other microbes [9–11]
immune system suppression suppression of the immune system may allow growth of other microbes [12]
immune system activation provocation of the immune system may clear commensals [13–15]
Table 2. A Hamiltonian classiﬁcation of social traits. Traits are classiﬁed
based on the signs of their lifetime effects on the actor and on recipients,
yielding a four-way classiﬁcation for the trait (behaviour or phenotype) of
interest. Note that ‘mutual beneﬁt’ (þ/þ) here refers to costs and
beneﬁts of the trait, and does not necessarily imply ecological mutualism
among species. After refs [42,43].
recipient 1 recipient 2
actor þ mutual beneﬁt selﬁsh
actor 2 altruistic spiteful
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these diverse changes.
‘Sociality’ and ‘niche construction’ are stronglyoverlapping
concepts. By broad definitions, they are entirely overlap-
ping ‘theories of everything’ that can describe all biological
traits, in so far as all traits affect a focal organism, and other
organisms via the inevitable impacts of an organism on its
environment. The classification of social behaviours most com-
monly follows Hamilton [42,43], who classified traits based on
lifetime direct fitness consequences of the trait to the actor (the
individual expressing the focal trait) and on fitness conse-
quences to recipients (other individuals impacted by the focal
trait; table 2; [42,43]). This classification has been extremely
influential in evolutionary biology and is increasingly applied
to understand adaptation in pathogenic microbes [44–46].
However, the powerful concision of this approach tends to
mask the environmental intermediaries that are central to
bacterial social interactions (adaptive and non-adaptive) and
impacts to the host [47], such as secreted proteins [3,4], metab-
olites [9–11,48], shared mobile genetic elements [49], changes
in pH [23], and changes in host immunity or gut flora [50].2. Adaptive, maladaptive and incidental niche
construction
A common criticism of niche construction theory is that it
considers all effects of an organism on its environment as
niche construction effects, whereas these effects may not be
significant for the evolution of the organismal traits contrib-
uting to environmental change [40,41]. As such, the niche
construction perspective can be accused of obfuscating the
ultimate causes of the evolution of a trait [40,41]. Here,
we illustrate that by combining social evolution and niche
construction perspectives into a single classification system
this limitation can be easily overcome.
Table 3 illustrates this classification of traits depending on
their effects on an actor, recipient, and also whether the trait
was selected for based on its effects on recipients via modifi-
cation of the environment. Note that a single actor trait
can have distinct classifications depending on the identity
of the recipient. This classification differs from the classical
Hamiltonian classification of behaviours in that it considers
effects on the environment (and therefore other organisms)that were not selected for, i.e. incidental effects. This leads
to three broad categories of niche-construction—incidental,
maladaptive and adaptive.
(a) Incidental niche construction
Incidental niche construction (INC) concerns the consequences
of ‘self-interested’ traits, traits that increase the direct fitness of
a focal individual, and may either increase (incidental mutually
beneficial niche construction) or decrease (incidental selfish niche
construction) the fitness of interactants via their effects on
the environment that have not been selected for. A large
proportion of bacterial interactions fall into the category of
incidental selfish niche construction, as most metabolic activity
will likely degrade the environment for other conspecifics,
though metabolic traits are unlikely to have generally been
selected for this purpose.However, incidental mutually beneficial
niche construction is also common (note that this mutualism
need not be ecological mutualism). By-products of selfish
microbial metabolism may be metabolized by heterospecific
microbes, in a process termed cross-feeding or syntrophy
[9–11], allowing both interactants to benefit from the selfish
metabolic trait even in the absence of any return of beneficial
services from the recipient to the actor.
(b) Maladaptive niche construction
Maladaptive niche construction (MNC) concerns traits that
reduce the fitness of the focal individual, and have not been
selected based on their effects on the social environment.
Such traits would be expected to appear only transiently as
they are entirely deleterious to the actor. However, for
Table 3. A Hamiltonian classiﬁcation of niche-constructing behaviours.
recipient 1 recipient 2
selected for effect
on environment
not selected for effect
on environment
selected for effect
on environment
not selected for effect
on environment
actor þ mutually beneﬁcial extended
phenotype, e.g. secretions
in medium to low
densities (EP)
incidental mutually beneﬁcial
niche construction, e.g.
cross-feeding (INC)
selﬁsh extended
phenotype, e.g.
intracellular pathogen
secretions (EP)
incidental selﬁsh niche
construction, e.g.
respiration (INC)
actor 2 altruistic extended phenotype,
e.g. secretions in high
density environments (EP)
maladaptive altruism, e.g.
inappropriate VF expression
(facilitating pathogen
invasion) (MNC)
spiteful extended
phenotype, e.g.
bacteriocin
secretions (EP)
maladaptive spite, e.g.
inappropriate virulence
factor expression
(damaging host) (MNC)
mutual benefit
altruistic spiteful
selfish(b)(a)
(c) (d )
Figure 1. Social calculus for costly secreted factors is dependent on density
and mixing of a population. Focal cell and focal cell niche-constructing beha-
viours are shown in black, interactants are shown in grey. (a–c) Secreted
public good molecule (e.g. iron-scavenging siderophore or extracellular diges-
tive enzyme). (d ) Lytically produced anti-competitor toxin (e.g. bacteriocin).
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a broad range of environments, the potential for locally
maladaptive gene expression in novel or rarely encountered
environments is increased. A recent comparative analysis of
bacterial pathogens of humans illustrated that more generalist,
zoonotic species carry a larger genomic repertoire of secreted
proteins [4]. This result suggests that generalist bacterial
pathogens have larger repertoires of niche-constructing behav-
iours, and by virtue of their environmental generalism are also
more likely to make regulatory ‘bad decisions’ in any specific
environment—such as within a human host [51]. Inappropri-
ate expression of a virulence factor (VF) in a host species or
disease site to which a pathogen is not adapted could lead to
negative effects for the focal individual and its neighbours,
appearing as maladaptive spite. Similarly, production of public
goods molecules when they are not of use to the focal individ-
ual and relatives, but could be of use to other species, could
create the appearance of maladaptive altruism.
(c) Adaptive niche construction or ‘extended
phenotypes’
Adaptive niche construction or ‘extended phenotypes’ (EP)
concerns traits that have been selected for based on their effects
on the environment [52]. These traits would be expected to
show a clear signature of being designed for their effects on
their environment of adaptation (which may not be the
human host). For example, for microbes, secreted proteins
would be expected to constitute adaptive niche construction
traits in their appropriate environment as they are costly to
produce and, given that they are secreted, must therefore
have been selected for their effects on their environment of
adaptation. Adaptive niche construction traits could poten-
tially fall into any of the Hamiltonian classifications of social
behaviour (figure 1):
— Mutually beneficial extended phenotype, e.g. production of
scavenging molecules (siderophores, etc.) at low densities
(figure 1a). Here, a focal producer receives a net gain owing
to the return of iron-loaded siderophores to their producer,
as well as gains to other neighbouring individuals [53].
— Altruistic extended phenotype, e.g. production of scavenging
molecules at high densities in well-mixed populations
(figure 1c). Here, a focal producer is highly unlikely toreceive a direct return on the molecules it has individually
produced, but the trait has been selected based on the
benefits received by relatives [53].
— Spiteful extended phenotype, e.g. suicidal production of
bacteriocins (figure 1d ). Here, a focal individual pays a
cost of the trait, but gains an indirect benefit by harming
individuals that are less related to them than average [6,7].
— Selfish extended phenotype, e.g. production of scavenging
molecules when alone or at low densities (figure 1a). Here,
a focal individual gains from modifying their environment
and harms others via environmental degradation (draw-
down of shared local resources and/or direct damage to
the host) [54].Adaptive niche construction traits will also inevitably have
additional incidental or maladaptive consequences, owing to
their impacts on other recipients. For example, adaptive invest-
ment in biofilm matrix production can change the physical
structure of an environment, producing dramatic changes in
flow rates [55], oxygenation [1,2] and can ultimately shift com-
munity structure [56–58] and lead to the local extinction of the
lineages that initially constructed the biofilm [2].
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encompassing both social evolution and niche construc-
tion perspectives, provides a more holistic view of both the
evolutionary causes, and ecological and environmental conse-
quences, of microbial social behaviours. However, a major
challenge exists in elucidating to which of these classes any
individual microbial behaviour belongs, and how classifi-
cations change with changing environmental contexts—for
instance, density, mixing, host and microbiome composition
(figure 1). However, we believe there are some general guiding
principles that can be applied. Whenever an instance of
microbial niche construction is caused by secretions/excretions
released by microbial cells, the mechanism of production of
these secretions can give insights into whether or not this
niche construction effect is adaptive in at least some environ-
ments. If these secretions are proteins, then we argue that the
protein’s anticipatedniche construction effectmust be adaptive
in an appropriate environment—why produce a costly large
molecule and release it from the cell if its expected net effect
on the environment is not beneficial to the actor and kin?
This view is also supported by the observation that secreted
proteins show a signature of selection for reduced biosynthetic
cost [49]. Similarly, if a secreted small molecule is produced by
dedicated synthase genes (e.g. siderophores, certain quorum-
sensing signal molecules [59]), it stands to reason that it must
have some adaptive niche construction function; otherwise,
the trait would be lost by selection. However, for excreted mol-
ecules that are by-products of selfish intracellular metabolic
processes, we argue that the niche-constructing impacts (such
as cross-feeding or syntrophic community structures) are
likely to be purely incidental effects.3. Utility of combining niche construction and
social evolution perspectives: managing
bacterial niche construction
The combination of niche construction and social evolution
perspectives promises a richer understanding of microbial
social behaviours. However, what value does this combination
of perspectives offer for our understanding, and ultimately
management, of our interaction with microbes?
Consider for example a bacterial VF. VFs are clearly niche-
constructing traits, as they are typically defined and identified
by their causal impact on host-level disease, in addition
to the requirement of being expendable in rich culture. In
short, they are molecular determinants of pathology, coded by
non-essential genes [60]. What would a niche construction per-
spective tell us about VFs? The focus of a niche construction
perspective would be on the effects of the virulence trait on the
environment through space and time. Key questions would be
(1) How is the microbiota affected?
(2) How is the immune system affected?
(3) How spatially diffuse are the effects (VF diffusion,
propagation, etc.)?
(4) How temporally elongated are the effects (VF durability,
immune memory, etc.)?
(5) How do impacts on immunity and other microbes
interact?
On the other hand, a social evolution perspective asks a very
different set of questions:(1) How does VF production affect the producer’s fitness?
(2) How does VF production affect the fitness of other
individuals?
(3) What is the relatedness between affected individuals and
producers?
(4) Ultimately, what was the VF selected for?
The niche construction perspective focuses on the range of
effects of the trait on the host environment through space and
time, and identifies potential consequences directly for host
health and those mediated by microbiota, immune system,
etc. This focus onmechanism is more alignedwithmainstream
microbiological approaches, and allows us to make inference
by homology—similar molecules in another organism will
likely have similar effects. In sum, the niche construction per-
spective identifies the full range of potential direct and
indirect impacts of the trait on the host and microbiota.
In contrast, the social evolution perspective tells us which of
these effects are important for the evolution of the trait, if
any (recognizing the potential for the trait to be sculpted by
selection in distinct environments [51,61]). By providing a diag-
nosis of the selectively relevant forces acting on the VF, a social
evolution perspective provides vital information on the poten-
tial evolutionary consequences of interfering with the trait in
different ways.
(a) Case study 1: Clostridium difficile dynamics in the
gut microbiome
As a concrete example, let us consider the recently discovered
suppression of Clostridium difficile infection by its cogener
C. scindens [62]. C. difficile is a ubiquitous soil-dwelling
microbe, and is found in a carriage state in the colon of
approximately 2–5% of the adult human population [63].
C. difficile is also a major opportunistic pathogen of humans
with disrupted gut microbiomes, notably following antibiotic
treatment. Antibiotic-associated reductions in the resident
commensal microbiota can lead to C. difficile colitis [64], a
dangerous condition and increasingly the target of contro-
versial ‘faecal transplant’ therapies, where faecal material
from healthy donors is used to repopulate the microbiome
of the patient [65]—a clear and dramatic example of medical
niche construction. While faecal transplants are reported as
an empirical success, the search for a mechanistic basis of
their efficacy is pressing, in order to replace faecal transplants
with defined therapeutic consortia.
Using a combination of metagenomics of the microbiome
of hospitalized patients and mouse model infections, Buffie
et al. [62] recently showed that the presence of C. scindens pro-
tects against infection with C. difficile via the biosynthesis of
secondary bile acids, which inhibit C. difficile growth. This
suggests that the use of C. scindens as a probiotic for patients
undergoing antibiotic treatment may help prevent debilitat-
ing C. difficile infections, without recourse to entire faecal
transplantation.
What does a joint niche construction and social evolution
perspective offer in terms of understanding this potential
new treatment? While C. difficile infections primarily occur
in the lower parts of the colon [66], C. scindens and other
secondary bile-acid-producing bacteria are thought to be pri-
marily active in the upper parts of the colon [67,68]. Thus,
the production of secondary bile acids by C. scindens is analo-
gous to the canonical example of niche construction—a
C.
 sc
ind
en
s
competitor?
upper colon lower colon
bile acid
modified bile
direct benefit?
direct cost?
local benefit?
incidental local effect?
distant benefit?
incidental downstream effect?
C. difficile
Figure 2. The niche construction effect of bile acid modification by C. scindens. Dehydroxylation of bile acids by C. scindens at the caecum (upper colon) leads to
suppression of C. difficile in the lower colon. Bile acid modification may directly yield energy for C. scindens, but may also suppress the growth of local competitors,
which could be an adaptive or incidental function. Finally, the downstream effect of C. scindens on C. difficile may either provide benefits via immune system
interaction or may be incidental.
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environment (figure 2).
Whereas the biomedically significant effects of enzymat-
ically modifying bile acid are downstream of the actor, the
nature and localization of the costs and benefits to the actor
are currently unknown (figure 2). We anticipate that the sup-
pression of C. difficile has negligible impacts on C. scindens
owing to their significant spatial segregation (although
immune-mediated interactions are possible). It is more
likely that bile acid modification provides local benefits to
C. scindens, through the chemical suppression of local (and
currently unidentified) competitors. Finally, it is possible
that dehydroxylation of primary bile acids directly yields
energy for C. scindens, and all extracellular impacts are inci-
dental for the focal actor. Critical to elucidating which of
these scenarios holds will be characterizing the temporal
and spatial extent of the costs and benefits of secondary
bile acid synthesis to C. scindens, its local interactants, and
downstream players including C. difficile. If bile acid modifi-
cation is driven by direct metabolic gains (i.e. INC), then the
microbiome management goal will be to increase profitability
of this reaction (potentially via diet, prebiotics). In contrast, if
the trait is driven by local competitive gains, then manage-
ment might involve manipulating competitive cues driving
expression of the enzymatic modification. In either case,
understanding the social and non-social selection pressures
governing bile acid modification is critical for ensuring any
such intervention is robust to potential within host evolution
of C. scindens and its interactants.(b) Case study 2: Pseudomonas aeruginosa dynamics
in the cystic fibrosis lung microbiome
Cystic fibrosis (CF) is a genetic condition that primarily affects
the lung, leading to impairedairway clearanceand the establish-
ment of chronic lung infections. Chief among the multiple
microbial pathogens of the CF lung is the environmental
generalist bacterium and opportunistic pathogen, Pseudomonas
aeruginosa. In linewithother generalist opportunistic pathogens,
P. aeruginosa is characterized by a broad arsenal of secreted
‘VFs’, with the typical genome carrying 60 or more genes
coding for secreted proteins, spanning toxins, exoenzymes
and immunomodulatory factors [4]. On initial colonization of
mammalian tissues, many of these secreted factors are upregu-
lated [69,70]. However, during subsequent evolution within
chronically infected CF patients, many of these secreted factorsare subsequently lost [71–74]. The loss of collectively produ-
ced VFs has led social evolution theorists to suggest that the
within-host evolutionary dynamics is due to social interac-
tions favouring non-producing ‘cheater’ strains that exploit the
benefits, but do not pay the costs of collective action [75,76].
However, it is also possible that the benefits of VF expression
change in timeowing toa successional process of environmental
modification—in the early stages of lung colonization, secreted
factors are beneficial in remodelling the lung environment, and
then only later on do they become redundant [51]. Finally, it is
possible that these VFs are always redundant in the lung and
that their initial upregulation was a regulatory mistake, a ‘bad
decision’ resulting from a severe environmental mismatch
[51]. The potentially widespread existence of regulatory mis-
takes in generalist microbes was recently highlighted in a
study of P. aeruginosa acute burn and chronic wound infections,
which found no correlation between gene expression level and
selection on a mutant—P. aeruginosa is just as likely to upregu-
late redundant genes and downregulate useful genes as the
converse [77].
Understanding the relative roles of these three non-exclu-
sive hypotheses (cheating, succession and redundancy) is
important from a management perspective. One emerging
therapeutic option to manage P. aeruginosa virulence in
CF lung infections is the use of ‘anti-virulence’ drugs. Anti-
virulence (AV) drugs act by chemically suppressing the
expression or functioning of bacterial VFs [60]. If VFs are
purely redundant within the lung, then chemically suppressing
their activity could even lead to selection against resistance [60].
Similarly, if VFs are collectively beneficial and prone to cheater
exploitation, then drug treatment could select against resistant
cells—but only if resistant ‘cooperators’ and sensitive ‘cheats’
are sufficiently well mixed [60,78]. Finally, if the benefits of
VF expression are temporally variable, then the picture becomes
yet more nuanced and dependent on the successional stage of
the infection process.
(c) Case study 3: Provocation of the host immune
response by Salmonella enterica serovar
Typhimurium
One of the most dramatic ways in which bacteria can modify
the within-host environment they experience is by provoking
the host immune system in order to clear competitors [13].
If a pathogen is suitably protected, eliciting a strong immune
response could facilitate its invasion by clearing commensals
rstb.royalsocietypublishing.org
Phil.Trans.R.Soc.B
370:20140298
6
 on July 8, 2015http://rstb.royalsocietypublishing.org/Downloaded from and other competing pathogens from the infection site [14,36].
Many examples of this behaviour have been characterized in
bacteria, including provocation of immune response by inflam-
mation-promoting toxins or immunogenic factors in E. coli
O157:H7 [79,80], Streptococcus pneumoniae [81,82] andC. difficile
[83–85], leading to clearance of commensal competitors, and
by recruitment of neutrophils into the paranasal spaces by
Haemophilus influenzae, leading to the clearance of its com-
petitor S. pneumoniae [15]. Interestingly, in this last example,
provocation of the immune system by H. influenzae may have
selected for more virulent serovars of S. pneumoniae, which
can resist this immune response [86]. While for many of these
examples, it is unclear whether this inflammation is adaptive,
one of the most well-described examples of adaptive immune
provocation occurs in the enteric pathogen Salmonella enterica
serovar Typhimurium.
Pathogenic salmonella, like other enteric food-borne
pathogens, face a dramatic ecological challenge on entering
the digestive tract: the presence of a diverse and saturated eco-
system of resident and presumably locally adapted microbes.
Stecher et al. [13] demonstrated that S. typhimurium can
overcome resident microbiome competitive suppression by
provoking an inflammatory host immune response to preferen-
tially clear commensal competitors. In order to overcome
competition from the commensal microbiota, S. typhimurium
uses type III secretion system 1 (T3SS-1) to manipulate and
invade gut tissue and induce inflammation in the host, to
which S. typhimurium is resistant [13]. Expression of these
VFs is regulated by a stochastic bistable switch, with only a
subpopulation of S. typhimurium expressing the trait. This
means that, despite most of the cells invading the gut tissue
being killed, cooperators can gain indirect benefits by enhan-
cing the growth of relatives in the gut lumen [87]. However,
this behaviour has been shown to also benefit avirulent cheater
strains (unable to switch to the virulent, sacrificial phenotype),
allowing the cheater strain to increase in frequency within the
host [88]. This would initially suggest that provocation of the
host immune response is an altruistic extended phenotype, imply-
ing that anti-virulence drugs [60,89], or even treatment with
cheater strains (‘cheat therapy’ [90]), may be an evolutionarily
robust way to manage S. typhimurium virulence.
However, the picture becomes more complicated when we
consider the effects of antibiotic treatment on the evolutionary
dynamics of this trait. Ciprofloxacin treatment has been shownto reduce the ability of cheats to invade WT S. typhimurium
during infection [91,92]. This occurs as S. typhimurium cells
that have invaded the gut tissue are protected from the effects
of the antibiotic, acting as a ‘persister’ subpopulation [91],
whereas cheaters and cooperators in the gut lumen are cleared
by the antibiotic [91]. A small proportion of the cooperators
that have invaded the gut tissue then re-seed the infection in
the lumen [91]. These results highlight that under antibiotic
treatment the benefits of expression of the virulent pheno-
type (survival in a persistence state/location) become direct,
whereas the environmentalmodifications likely become redun-
dant (competitor clearance is now driven by antibiotics). In this
scenario, the virulent phenotype becomes a case of incidental
selfish niche construction, and there will be strong selection for
resistance to any anti-virulence drug (andwithin-host selection
against cheats), reducing the evolutionary robustness of this
treatment strategy. Under antibiotic treatment, a more promis-
ing approach may be to try to manage the niche construction
effects (i.e. inflammation) caused by tissue invasion.4. Conclusion
The evolutionary management of infectious diseases needs
clear focus on both the effects of microbes on their environ-
ment and the consequent selection pressures of these effects.
Whether adaptive or not, elucidating the niche construction
effects of microbes is critical as they are likely to impact on
host health. However, we also need to clearly delineate the
subset of impacts that have a selective relevance—the direct
and indirect costs and benefits of a pathogen trait—as it is
this social evolution cost–benefit analysis that governs the tra-
jectories of biomedically significant traits (e.g. drug resistance,
virulence, emergence, microbiome resilience) through very
rapid evolutionary time.
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